Cardio Diagnostics Holdings Inc
Save
OverviewDividend safetyDividendsFundamentals
14.79M
Market cap
–
Current P/E
–
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Similar securities

Based on sector and market capitalization

Purple Biotech
Inhibitor Therapeutics, Inc.
Simply Better Brands Corp.
Celyad Oncology SA
Union Dental Holdings Inc
Nova Leap Health Corp.
Report issue